EU In Talks With Moderna Over New Covid Vaccine Deal
Portfolio Pulse from Charles Gross
The European Union is in discussions with Moderna Inc. for a new deal to secure additional doses of its COVID-19 vaccine. The deal is expected to include the purchase of new versions of the vaccine that could be more effective against variants of the virus.
September 26, 2023 | 12:17 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Moderna Inc. is in talks with the EU for a new deal to secure additional doses of its COVID-19 vaccine. This could potentially increase the company's revenues.
The news of a potential new deal with the EU for additional doses of its COVID-19 vaccine is directly related to Moderna Inc. This could lead to increased revenues for the company, which could positively impact its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEUTRAL IMPACT
The Vanguard FTSE Europe ETF (VGK) could be indirectly impacted by the EU's potential new deal with Moderna for additional doses of its COVID-19 vaccine.
The Vanguard FTSE Europe ETF (VGK) could be indirectly impacted by the EU's potential new deal with Moderna. While the ETF does not directly hold Moderna's stock, the overall European market sentiment could be influenced by the deal, which could in turn affect the ETF.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 50